Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2015-10-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Proprioceptive and Functional Characteristics in Patients With Hemophilia
NCT02165592
Clinical and Laboratory Patterns of Pediatric Gross Hematuria
NCT06504771
Quality of Life in Hemophilia by Clinical Scoring System (FISH)Score
NCT04102046
Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping Instrument
NCT00772434
Value of an Integral Color Scale on Urine Collection Bags Versus Use of a Strip in Description of Hematuria.
NCT03408288
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients adults
Sample of patients with haemophilia over 18 years of age that will participate in piloting of reliability and validity of the Spanish version of the HAL and HEP questionnaires
No interventions assigned to this group
Children with haemophilia
Sign hemophilia patients under 18 years of age that will participate in piloting of reliability and validity of the Spanish version of the HAL and HEP questionnaires
No interventions assigned to this group
Parents of children with haemophilia
Sample of parents of children with hemophilia under 18 years of age that will participate in piloting of reliability and validity of the Spanish version of the HAL and HEP questionnaires
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parents of children with hemophilia A and B, under 18
* Patients who have previously signed the informed consent document
Exclusion Criteria
* Patients with cognitive impairment, or oral or written understanding
8 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Católica San Antonio de Murcia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rubén Cuesta-Barriuso, PhD
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
RUBEN CUESTA-BARRIUSO, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidad Católica San Antonio
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad de Murcia
Murcia, Murcia, Spain
Universidad Católica San Antonio, Murcia
Murcia, Murcia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VALIDATION
Identifier Type: -
Identifier Source: secondary_id
VALIDATION
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.